# A Phase 3, Vehicle-controlled Efficacy and Safety Study of IDP-123 Lotion in the Treatment of Acne Vulgaris (301)

> **NCT03168321** · PHASE3 · COMPLETED · sponsor: **Bausch Health Americas, Inc.** · enrollment: 813 (actual)

## Conditions studied

- Acne Vulgaris

## Interventions

- **DRUG:** IDP-123 Lotion
- **DRUG:** IDP-123 Vehicle Lotion

## Key facts

- **NCT ID:** NCT03168321
- **Lead sponsor:** Bausch Health Americas, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-06-29
- **Primary completion:** 2018-06-07
- **Final completion:** 2018-06-07
- **Target enrollment:** 813 (ACTUAL)
- **Last updated:** 2021-04-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03168321

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03168321, "A Phase 3, Vehicle-controlled Efficacy and Safety Study of IDP-123 Lotion in the Treatment of Acne Vulgaris (301)". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT03168321. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*